NCT00934934View on ClinicalTrials.gov

Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment

PHASE2TerminatedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Ventilator Associated PneumoniaRespiratory Tract Infection
Interventions
OTHER

Normal Saline

Normal Saline

DRUG

anidulafungin

TBA

Trial Locations (6)

Unknown

Hamilton Health Sciences Centre, Hamilton

Ottawa General Hospital, Ottawa

K7L 2V7

Kingston General Hospital, Kingston

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

H4J 1C5

Hopital du Sacre-Coeur do Montreal, Montreal

G1J 1Z4

Hopital l'Enfant-Jesus, Québec

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

collaborator

Queen's University

OTHER

collaborator

Pfizer

INDUSTRY

lead

Daren K. Heyland

OTHER

NCT00934934 - Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment | Biotech Hunter | Biotech Hunter